Skip to content
★ Sign in to follow
DJ

David J. Loury

Executive
Pharmacyclics Inc
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€3.9M

Latest filing published 06 Nov 2013 for PHARMACYCLICS INC, €8,764.

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

No signal scores available.

David J. Loury: trading record in brief

David J. Loury appears in our data through filings on Pharmacyclics Inc shares, published by SEC (Form 4). We count 16 filings; the first trade dates from 30 October 2009 and the latest from 31 October 2013.

Every open-market trade on record is a sale: 5 sales worth €3.9M. Besides market trades, the filings include 3 option exercises. Since January 2013: no purchases and 4 sales on the market.

The newest entry dates from 6 November 2013: a transaction of €8,764, in Pharmacyclics Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David J. Loury

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ●
    Executive VP, ToxicologyExecutivesPharmacyclics Inc
    12,028 USD0SEC
    1,139 shares@ US$10.56Common StockSEC:0001209191-13-050965:0
  • ●
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    1,732 USD0SEC
    164 shares@ US$10.56Common StockSEC:0001209191-13-023487:0
  • ◇
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    55,200 USD0SEC
    20,000 shares@ US$2.76Common StockSEC:0001209191-13-006630:0
  • ▼
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    1M USD0SEC
    20,000 shares@ US$70.58Common StockSEC:0001209191-13-006630:1
  • ▼
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    43,809 USD0SEC
    10,531 shares@ US$4.16Common StockSEC:0001209191-13-002780:0
  • ▼
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    698,205 USD0SEC
    10,531 shares@ US$66.30Common StockSEC:0001209191-13-002780:1
  • ◇
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    41,600 USD0SEC
    10,000 shares@ US$4.16Common StockSEC:0001209191-13-002618:0
  • ▼
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    647,000 USD0SEC
    10,000 shares@ US$64.70Common StockSEC:0001209191-13-002618:1
  • ◇
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    164,191 USD0SEC
    39,469 shares@ US$4.16Common StockSEC:0001209191-12-059165:0
  • ▼
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    2M USD0SEC
    39,469 shares@ US$61.12Common StockSEC:0001209191-12-059165:1
  • ●
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    1,721 USD0SEC
    163 shares@ US$10.56Common StockSEC:0001209191-12-051545:0
  • ●
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    1,711 USD0SEC
    162 shares@ US$10.56Common StockSEC:0001209191-12-025614:0
  • ●
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    5,195 USD0SEC
    3,227 shares@ US$1.61Common StockSEC:0001209191-11-054004:0
  • ●
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    16,100 USD0SEC
    10,000 shares@ US$1.61Common StockSEC:0001209191-11-025884:0
  • ●
    Chief Scientific OfficerExecutivesPharmacyclics Inc
    16,100 USD0SEC
    10,000 shares@ US$1.61Common StockSEC:0001209191-10-052643:0

15 of 15 declarations